Minoryx Therapeutics receives US FDA fast-track designation for leriglitazone in the treatment of X-ALD

Post by: Geert in Minoryx Press Release
Minoryx Therapeutics receives US FDA…
read more
09 Jan 2020
0

Novadip Biosciences to present data at 17th Annual Meeting of the International Federation for Adipose Therapeutics and Science

Post by: Geert in Novadip Press Release
Novadip Biosciences to present data…
read more
04 Dec 2019
0

Minoryx Therapeutics receives Orphan Drug Designation from the European Commission for leriglitazone in the treatment of Friedreich’s Ataxia

Post by: Geert in Minoryx Press Release
Minoryx Therapeutics receives Orphan Drug…
read more
13 Nov 2019
0

Business Alliance between Promethera Biosciences SA and MEDIPAL HOLDINGS

Post by: Geert in Press Release Promethera
Notice of Business Alliance between…
read more
13 Nov 2019
0

EyeD Pharma CEO Melanie Mestdagt in the news

Post by: Geert in EyeD Pharma News article
EyeD Pharma CEO Melanie Mestdagt…
read more
28 Oct 2019
0

Minoryx Therapeutics receives FDA Orphan Drug Designation for leriglitazone in Friedreich’s Ataxia

Post by: Geert in Minoryx Press Release
Minoryx Therapeutics receives FDA Orphan…
read more
17 Oct 2019
0

Immunic, Inc. Expands Board of Directors with Appointment of Industry Veteran Tamar Howson

Post by: Geert in Immunic Press Release
Immunic, Inc. Expands Board of…
read more
16 Oct 2019
0

Immunic, Inc. Announces Completion of Enrollment for its Phase 2 EMPhASIS Trial of IMU-838 in Patients with Relapsing-Remitting Multiple Sclerosis

Post by: Geert in Immunic Press Release
Immunic, Inc. Announces Completion of…
read more
11 Oct 2019
0

Minoryx: Un axe Espagne-Belgique pour sauter la barrière

Post by: Geert in Minoryx News article
Minoryx News Article: Un axe…
read more
09 Oct 2019
0

Minoryx Therapeutics completes enrollment in FRAMES phase 2 trial with leriglitazone in Friedreich’s Ataxia

Post by: Geert in Minoryx Press Release
Minoryx Therapeutics completes enrollment in…
read more
08 Oct 2019
0